Eligibility to partake in sports is withheld from patients with severe aortic valvular stenosis or moderate–severe insufficiency. 8 Previous studies have shown the progression of valve dysfunction in ...

Permanent pacemaker rates were nearly 18% at 30 days but came down as sites gained experience with the new device.

A true test of durability will take many more years, but if the valve holds up, it’s “potentially a game changer,” say ...

Objective Aortic regurgitation (AR) after transcatheter aortic valve implantation (TAVI) is associated with a poor clinical outcome and its assessment therefore crucial. Quantification of AR by ...

To determine the impact of tricuspid regurgitation (TR) on outcomes after transcatheter aortic valve implantation (TAVI), and to determine the evolution of TR severity after TAVI. This was an ...

Objective This study aims to evaluate the role of antiphospholipid antibodies (aPLs) in patients with SLE with heart valve ...

It was reported that the prevalence of aortic valve sclerosis, calcification or thickening was approximately 21%–31% in subjects ≥65 years of age. 4 5 According to the Framingham Study, the prevalence ...

Background The transthoracic echocardiographic (TTE) evaluation of the severity of residual aortic regurgitation (AR) following transcatheter aortic valve implantation (TAVI) has been controversial ...

For the estimated 1.6 million Americans diagnosed with symptomatic tricuspid valve regurgitation each year, a significant ...

Transcatheter aortic valve implantation (TAVI) is now an established treatment option for elderly patients with severe ...

The treatment for valvular regurgitation depends on the underlying cause and severity. Mild cases might not need any treatment, but your doctor may still want to follow up regularly to ensure your ...